A study published in PLOS One by Yao Zhao at Temple University, U.S., and colleagues suggests that wearable devices can provide accurate, longitudinal sleep data to facilitate analyses of changing sleep patterns over time.
Researchers at UNSW Sydney have developed a fully synthetic soft robotic heart that reproduces the complex movements and internal structures of the human heart, opening the door to better treatments, safer medical devices and more personalized care.
A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to new research led by UCL and University of Oxford researchers.
To make earlier diagnosis easier, an MIT team has developed portable detectors based on ultrasound, which could be used much more frequently.
Small loops of genetic material may be strong indicators of imminent Alzheimer’s disease (AD) symptoms. In a new study published in Nature Medicine, researchers showed that elevated levels of certain circular RNAs (circRNAs) in the blood nearly tripled patients’ risk of developing symptoms, suggesting these molecules are more sensitive to symptom onset than traditional AD biomarkers.
SINGAPORE, July 1, 2026 /PRNewswire/ — NICE Surgical Solutions Pte Ltd (“NICE Surgical”), a clinical-stage medical device company pioneering full intracorporeal anastomosis surgical instruments has been officially granted the U.S. Patent No. 12,653,527 B2, for its purse-string stapler.
SkylineDX’s test stratifies cutaneous melanoma patients into metastatic risk categories to inform treatment decisions.
The comprehensive review in which this discovery was first made is published in Nature Reviews Bioengineering and was led by Giacomo Valle, assistant professor at Chalmers University of Technology in Sweden.
A collaborative research team led by National Yang Ming Chiao Tung University and National Taiwan University investigated the therapeutic potential of gene therapy administered after birth.
In a new study published in Cell Stem Cell, the researchers developed a patient-derived organoid platform to uncover how chronic pancreatitis develops at the molecular level and identify possible therapeutic strategies.